Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1097/TP.0000000000003784 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Chronic heart failure and hypoalbuminemia are risk factors of poorer mRNA SARS-CoV-2 vaccine response in maintenance Hemodialysis patients (the COVaccinDia study).
BMC Nephrol
June 2025
Department of Nephrology, Dialysis, and Transplantation, Limoges University Medical Center, 2 avenue Martin Luther King, Limoges, F-87042, France.
Background: Chronic kidney disease represents an immunocompromising condition and a cause of a lower vaccine efficacy, even in patients undergoing maintenance dialysis. Recent SARS-CoV-2 outbreaks have prompted clinicians to better understand the underlying mechanisms and establish more suitable vaccination schedules.
Methods: In a single-center, retrospective, observational study of patients undergoing maintenance dialysis in France, we studied the factors associated with the intensity of the humoral response to a SARS-CoV-2 vaccine in this population, including specific dialysis-related variables.
Comparative evaluation of in-house ELISA and two commercial serological assays for the detection of antibodies against SARS-CoV-2.
Sci Rep
April 2025
School of Medical Laboratory Science, Institute of Health, Jimma University, Jimma, Ethiopia.
The in-house ELISA SARS-CoV-2 serological assay, developed by the Armauer Hansen Research Institute (AHRI) in Ethiopia, measures anti-SARS-CoV-2 receptor binding domain (RBD) antibodies. This study aimed to compare the performance of our cost-effective in-house ELISA with two established commercially available SARS-CoV-2 antibody detection assays during the pre-Omicron COVID-19 pandemic. In April 2021, serum samples were collected from 1441 students across 60 schools in Oromia, from 15 hotspot districts and towns.
View Article and Find Full Text PDFAnti-SARS-CoV-2 and anticancer properties of triptolide and its derived carbonized nanomaterials.
Cancer Lett
June 2025
Graduate Institute of Biomedical Sciences, China Medical University, Taichung, 406040, Taiwan; Graduate Institute of Biochemistry and Molecular Biology, China Medical University, Taichung, 406040, Taiwan; Research Center for Cancer Biology, China Medical University, Taichung, 406040, Taiwan; Cancer
The COVID-19 pandemic remains an ongoing global health threat, yet effective treatments are still lacking. This has led to a high demand for complementary/alternative medicine, such as Chinese herbal medicines for curbing the COVID-19 pandemic. Given the dual anticancer and antiviral activities of many herbal drugs, they may hold a multifaceted potential to tackle both cancer and SARS-CoV-2.
View Article and Find Full Text PDFAge-related peculiarities of antibody-mediated humoral immune response following SARS-CoV-2 infection.
Exp Gerontol
May 2025
Neuroscience Laboratory, Cobrain Center, Yerevan State Medical University named after Mkhitar Heratsi, 0025 Yerevan, Armenia; Department of Biochemistry, Yerevan State Medical University named after Mkhitar Heratsi, 0025 Yerevan, Armenia. Electronic address:
Thousands of articles were published about the COVID-19 disease and hundreds about the immune response. But still little is known about the features of SARS-CoV-2-specific immunity in elderly. The aim of current research was to evaluate the age-related peculiarities of antibody mediated humoral immune response following SARS-CoV-2 infection.
View Article and Find Full Text PDFRole of Individual, Social and Health Factors as Determinants of COVID-19 Vaccine Hesitancy: Results from the Second Phase of the Italian EPICOVID19 Web-Based Survey.
Int J Environ Res Public Health
February 2025
Institute of Biomedical Technologies of the National Research Council, ITB-CNR, Segrate, 20090 Milano, Italy.
Background: Despite scientific breakthroughs in vaccine development, some people remain reluctant to accept the anti-SARS-CoV-2 vaccine. This study evaluates attitudes and behaviours towards the vaccine and factors associated with refusal/hesitancy at the start of Italy's vaccination campaign.
Methods: EPICOVID19 is a two-phase observational web-based study where adult volunteers completed questionnaires in April-June 2020 and January-February 2021.